Filing Details

Accession Number:
0001209191-18-048553
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-27 18:47:38
Reporting Period:
2018-08-23
Accepted Time:
2018-08-27 18:47:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411690 Bionano Genomics Inc BNGO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238935 J Christopher Twomey C/O Bionano Genomics, Inc.
9640 Towne Centre Drive, Suite 100
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-23 10,000 $6.13 10,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (right to buy) Acquisiton 2018-08-23 10,000 $0.00 10,000 $6.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 2023-08-21 No 4 P Direct
Footnotes
  1. Units purchased in the Issuer's Initial Public Offering for $6.125 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock.
  2. 9/21/18 or such earlier date as Roth Capital Partners LLC, as representative of the underwriters in the Company's Initial Public Offering, shall determine.